William Jackson is a Cardiology physician. ClinicalTrials.gov lists 2 registered studies matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Research metrics aren't shown for this record. Either we found no confident publication match for this name, or more than one physician shares the matched author record. We'd rather show nothing than someone else's numbers. Why? →
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
945 82nd Pkwy
Ste 3b
Myrtle Beach, SC 295724612
Telephone
843-839-1201Registry record last updated 20 Jan 2017.
Clinical trials
- Post-prostatectomy Radiation Therapy--Moderate Versus Ultra-hypofractionated (Also Known as Stereotactic Body Radiation Therapy [SBRT])
Sponsor: University of Michigan Rogel Cancer Center
- A Multi-Center Trial of Androgen Suppression With Abiraterone Acetate, Leuprolide, PARP Inhibition and Stereotactic Body Radiotherapy in Prostate Cancer
Sponsor: University of Michigan Rogel Cancer Center
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
46 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Edwards Lifesciences CorporationProgram year20252 payments
- Amgen Inc.Program year20257 payments
- Merck Sharp & Dohme LLCProgram year20256 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
78.7%Beta blocker19.8%Metoprolol Succinate37%Atenolol23%Carvedilol15%Metoprolol Tartrate12%Nebivolol Hcl7%Sotalol3%Labetalol Hcl2%Acebutolol Hcl1%Propranolol Hcl1%Part D<11 patientsStatin11.7%Atorvastatin Calcium50%Rosuvastatin Calcium34%Simvastatin10%Pravastatin Sodium6%Lovastatin1%Part D<11 patients+ 22 more classes in this area
Blood & clotting
16.3%Factor Xa inhibitor10.3%Eliquis69%Xarelto31%Part D≥202 patientsP2Y12 inhibitor3.9%Clopidogrel94%Prasugrel Hcl6%Part D<11 patients+ 2 more classes in this area
Metabolism & gastrointestinal
2.4%Proton pump inhibitor1.2%Pantoprazole Sodium70%Omeprazole30%Part D≥25 patientsPotassium supplement1%Potassium Chloride84%Klor-Con M2016%Part D<11 patients+ 2 more classes in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Similar KOLs
Other experts from the same institution or the same specialty.
Gregory Y.H. Lip
Medical University of Białystok
Mika Kivimäki
University of Helsinki
Salim Yusuf
Population Health Research Institute
Victoria Delgado
Institute of Molecular Bioimaging and Physiology
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”